Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
Fresenius Medical (FMS) Gets FDA Nod for New Hemodialysis System
Fresenius Medical (FMS) receives an FDA nod for its new 5008X Hemodialysis System that aims to provide better dialysis therapy for kidney patients in the United States.
Fresenius Medical (FMS) Divests Businesses to Optimize Portfolio
Fresenius Medical (FMS) streamlines for success with three key divestments in 2023. These divestments are likely to impact operating income by EUR 500 million in the fourth quarter.
Fresenius plans to sell rehabilitation care clinics - FAZ
Fresenius has hired UBS to manage the sale of its rehabilitation care clinic business as the German healthcare group focuses on core activities, Frankfurter Allgemeine Zeitung reported on Friday, c...
Fresenius Medical Care says data on 500,000 people stolen in U.S.
Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a U.S. subsidiary's database.
Fresenius Medical (FMS) Ups '23 Outlook After Legal Settlement
Fresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical (FMS) Q3 Earnings Miss, Operating Margin Up
Fresenius Medical's (FMS) third-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Call Transcript
Top Medical Stocks to Buy Amid Recent Market Volatility
Several Zacks Medical sector stocks were recently added to the Zacks Rank #1 (Strong Buy) list over the last week and should be viable options for investors during economic uncertainty as healthcar...
Fresenius Medical: use of drugs like Ozempic has neutral effect on dialysis patient numbers
Germany's Fresenius Medical Care , said that use of Ozempic, and other diabetes and weight-loss drugs of the same class, would have an overall neutral effect on how many patients will require the c...
Why Shares of Fresenius Medical Care Were Dropping on Wednesday
Novo Nordisk ended a phase 3 trial early for Ozempic for preventing kidney disease because the trial was so successful. Fresenius and other dialysis-connected companies saw their shares fall on Wed...
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.
Here's Why You Should Retain Fresenius Medical (FMS) for Now
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical's (FMS) New HHD Device to Increase Portability
Fresenius Medical (FMS) gets FDA clearance for Versi HD with GuideMe Software, a portable, home hemodialysis device with an easy-to-use graphical interface providing easier training experiences.
Related Companies